ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

Sector: Pharmaceutical Preparations Region: MA, United States

: | Nasdaq: ZIOP

Similar to: Mast Therapeutics, Inc., AstraZeneca Plc, Cephalon, Inc.

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.

News & Analysis

You may also be interested in: